Corrigendum to "DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice" [Pharmacol. Biochem. Beha. Volume 139, Part A, December 2015, Pages 15-26]. - Yang RY; Zhao G; Wang DM; Pang XC; Wang SB; Fang JS; Li C; Liu AL; Wu S; Du GH (Pharmacology, biochemistry, and behavior, 2024)